Intraperitoneal chemotherapy in older women with epithelial ovarian cancer

Chiara, 2001, Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapy, Crit Rev Oncol Hematol, 37, 27, 10.1016/S1040-8428(00)00088-3 Jemal, 2010, Cancer statistics, 2010, CA Cancer J Clin, 60, 277, 10.3322/caac.20073 Ries, 1993, Ovarian cancer. Survival and treatment differences by age, Cancer, 71, 524, 10.1002/cncr.2820710206 Thigpen, 1993, Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience, Cancer, 71, 606, 10.1002/cncr.2820710218 Winter, 2007, Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study, J Clin Oncol, 25, 3621, 10.1200/JCO.2006.10.2517 Kosary, 1994, FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973–87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina, Semin Surg Oncol, 10, 31, 10.1002/ssu.2980100107 Gershenson, 1993, Age contrasts in patients with advanced epithelial ovarian cancer. The M.D. Anderson Cancer Center experience, Cancer, 71, 638, 10.1002/cncr.2820710223 Moore, 2004, An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study, Gynecol Oncol, 94, 368, 10.1016/j.ygyno.2004.05.033 Uyar, 2005, Treatment patterns by decade of life in elderly women (> or =70years of age) with ovarian cancer, Gynecol Oncol, 98, 403, 10.1016/j.ygyno.2005.04.037 Sundararajan, 2002, Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study, J Clin Oncol, 20, 173, 10.1200/JCO.20.1.173 Edmonson, 1993, Treatment of ovarian cancer in elderly women. Mayo Clinic-North Central Cancer Treatment Group studies, Cancer, 71, 615, 10.1002/cncr.2820710219 Bicher, 1993, Age does not influence taxol dose intensity in recurrent carcinoma of the ovary, Cancer, 71, 594, 10.1002/cncr.2820710216 Eisenhauer, 2007, Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum–taxane chemotherapy, Gynecol Oncol, 106, 381, 10.1016/j.ygyno.2007.04.012 Kothari, 2010, The effect of age on the tolerability of intraperitoneal chemotherapy, complication rate, and survival in patients with ovarian cancer, Gynecol Oncol, 119, 491, 10.1016/j.ygyno.2010.08.026 Pignata, 2004, Ovarian cancer in the elderly, Crit Rev Oncol Hematol, 49, 77, 10.1016/S1040-8428(03)00100-8 Matulonis, 2009, Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Mullerian tumors, Gynecol Oncol, 112, 394, 10.1016/j.ygyno.2008.10.015 Repetto, 2002, Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study, J Clin Oncol, 20, 494, 10.1200/JCO.20.2.494 Armstrong, 2006, Intraperitoneal cisplatin and paclitaxel in ovarian cancer, N Engl J Med, 354, 34, 10.1056/NEJMoa052985 Alberts, 1996, Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer, N Engl J Med, 335, 1950, 10.1056/NEJM199612263352603 Markman, 2001, J Clin Oncol, 19, 1001, 10.1200/JCO.2001.19.4.1001 Ferguson, 2006, Toxicities of modified outpatient regimen of IV/Ip Paclitaxel and Ip Cisplatin in women with newly diagnosed ovarian cancer: 0123, Int J Gynecol Cancer, 16, 635 Trotti, 2003, CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment, Semin Radiat Oncol, 13, 176, 10.1016/S1053-4296(03)00031-6 Nordin, 2001, Do elderly cancer patients care about cure? Attitudes to radical gynecologic oncology surgery in the elderly, Gynecol Oncol, 81, 447, 10.1006/gyno.2001.6178 Bruchim, 2002, Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancer, Gynecol Oncol, 86, 274, 10.1006/gyno.2002.6759 Hurria, 2005, Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer, Drugs Aging, 22, 785, 10.2165/00002512-200522090-00007 Repetto, 2003, Greater risks of chemotherapy toxicity in elderly patients with cancer, J Support Oncol, 1, 18 Balducci, 2000, Management of cancer in the older person: a practical approach, Oncologist, 5, 224, 10.1634/theoncologist.5-3-224 Hurria, 2010, Predicting chemotherapy toxicity in older adults with cancer: a prospective 500 patient multicenter study, J Clin Oncol, 28, 9001, 10.1200/jco.2010.28.15_suppl.9001 Rockwood, 1999, A brief clinical instrument to classify frailty in elderly people, Lancet, 353, 205, 10.1016/S0140-6736(98)04402-X Extermann, 1998, Comorbidity and functional status are independent in older cancer patients, J Clin Oncol, 16, 1582, 10.1200/JCO.1998.16.4.1582